General description
Trastuzumab is a monoclonal antibody used in the treatment of human epidermal growth factor receptor 2 positive (HER2+) breast cancer.
INN
Trastuzumab
ATC codes
Medicine type
Biological agent
EML status history
First added in 2015
(TRS
994)
for
Carcinoma of breast, specialised type
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection
Indications